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Abstract
SARS-CoV-2 pandemic issue threatening world health and economy became a 
major problem with its destructive impact. The researchers have seen that conven-
tional methods related to medicine and immunological background do not resolve 
this disease by gained knowledge of viruses previously studied. Advances in com-
putational biology comprising bioinformatics, simulation, and yielded databases 
have accelerated and strengthened our facilities to predict some cases related to the 
biological complex by comparison with the use of artificial intelligence. Various 
novel drugs by using in silico resources and in vivo imaging techniques associated 
with high-resolution technologies can cause the confidential development of 
methods for the detection of antiviral drugs and the production of diagnosis kits. In 
the future, we will start seeing these novel techniques’ positive reflection and their 
advantages in cost/time effective profits. This chapter highlights these approaches 
and addresses updated knowledge currently used for research and development.
Keywords: Computational biology, Drug discovery, Genomics, Omics science, 
SARS-CoV-2
1. Introduction
Coronaviruses (CoVs) are positive-strand RNA viruses belonging to the order 
of Nidovirales including three families Arteriviridae, Coronaviridae, and Roniviridae 
[1]. Relied on the genetic studies, they classify CoVs into four genera as alpha, 
beta, gamma, and delta CoVs [2]. The diameter of CoVs is between 80 to 120 nm 
and their shapes are spherical. The fundamental structural proteins of CoVs are 
envelope (E), membrane (M), nucleocapsid (N), and spike (S) [1]. Its RNA genome 
composes of six to ten open reading frames (ORFs) [3].
The new studies will fill the knowledge gaps to reveal how the virus is evolving 
and adapting to new conditions. In recent years, the advanced findings on nucleic 
acid amplification technologies have been the reason for improving of automated 
DNA sequencing with the help of bioinformatics tools to characterize and clas-
sification of all kinds of infectious disease agents. One of the single-stranded RNA 
viruses, the Coronaviruses, has been classified using molecular tools. On sequence 
analysis, the genomes were identified by direct RNA extraction of the clinical 
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specimens isolated from nasopharyngeal aspirate or stool, as the template, since the 
viruses are non-cultivable [4–11]. The collection of SARS-CoV-2 sequences has been 
started in 2020 under the GISAID database. The analysis of viral genomes provided 
the preventing of possible viral mutations during in vitro viral replication. These 
provided data helped us to understand the virus, threatening the world health, at 
genomic and in silico levels, which gave rise to new experiments carried out in the 
laboratory. Protein function prediction methods mainly fall into sequence- and 
structure-based approaches. Using precisely important databases and tools relied 
on comparison for sequence, structural differentiation, and gene ontology enables 
us to find exact protein function annotation [12]. Given the destructive effect of the 
virus SARS-CoV-2 on human health and its contagious virulence, it has attracted 
the attention of researchers to find its efficiently curative method. We have realized 
that antiviral chemotherapy with small molecules for their properties as nucleoside 
analogs can identify new uncharacterized viral genes for producing antiviral drugs 
related to viral glycoproteins to cellular receptors, viral regulatory proteins. These 
drugs may block the synthesis and replication of the viral genome that induce the 
host immune response [13, 14].
These targeted regions can reduce the crucial function required for survival 
of the virus, by polymerase and/or protease assay enabled us getting of high 
throughput screening for identification of inhibitor small molecules and enzymes, 
which can be beneficial for the development of effective antiviral components 
and synthesized novel molecules [15]. Understanding of viral gene products 
could overcome the challenge of the development of antiviral drugs contributing 
to essential functions on the virus, with assays carried out in vitro considering 
molecular mechanisms involved in gene products and biochemical processes. New 
technology related to omics science is suggesting novel possibilities to find the right 
answers to inquiries resulting from unexplored pathogenic behavior of the virus. 
Bioinformatics promises to generate new knowledge on virus and host interaction 
that can help drive the efforts in more detail to the discovery and development 
of antiviral therapies [16]. Genomics, proteomics, and related technologies will 
also be beneficial in molecular virology as suited techniques and approaches for 
big data.
2. Bioinformatics and computational tools
The progress in the fields of genomics and proteomics are encouraging biologi-
cal studies on the virus. Genomic sequences and bioinformatics are also major 
tools in this field and quantities of raw data which has tremendously increased 
besides their complexity. Therefore, significant computational resources required 
to manage the volumes of data and their manipulation, researchers studying in 
these fields for any future drug discovery projects are using these new technologies. 
Bioinformatics resources (GISAID; NCBI) required to analyze the data, identify 
patterns and display the patterns help to investigators for understanding the 
problem, testing, and confirmation of their hypothesis in the laboratory to focus on 
prioritized compounds or genes [17]. Computational methods applied in the study 
of SARS-CoV-2 could be paved for the characterization of the virus collected from 
unique specimens and comparison with similar genomes resulted from sequence 
similarity. Comprehensively studied investigations on the characterization of the 
viruses to set a unique set of well-described genomes compared within each other 
have been reported [18]. Bioinformatics workflows and tools related to SARS-CoV-2 
to the detection of potential drug targets and providing beneficial knowledge on 
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therapeutic strategies have also been recently acknowledged [19]. New bioinformat-
ics tools applied to these genomes to test their ability and to predict the organization 
of viral genes involving coding capacity and the function of the viral proteins are 
commonly used [20]. These tools are assisting for the confirmation of transcrip-
tional patterns, gene expression, and gene function which are essential studies 
earlier than in vitro studies not to lose time and labor cost [21].
Data relevant to the discovery of new drugs contain information related to 
biological function, chemical structure, and the biologic activity of small molecules 
that all findings can help for the searching for new compounds. Even the nature 
of this problem is inherently complex, bioinformatics is a useful tool to handle the 
volumes of data required with databases. Small molecule inhibitors could target the 
computational methods, suggesting aspects of the viral genomic property. Then 
they may be the reason for identification of the small molecules well-described with 
their biological effects, which could be used to probe for following of the cellular 
functions related to chemical structure, protein structure, biochemical activity, and 
biologic activity of the virus. As another branch of data mining on whole existing 
data shows a way for screening on inhibitory chemicals with known biochemical 
activities according to their chemical classes.
3. Impact of omics science and related fields on SARS-CoV-2 research
With advanced techniques and bioinformatics tools, the scientific landscape 
has dramatically changed in recent years. The huge data yielding on omics science 
plays an important role in the steps related to the biology of SARS-CoV-2 infections 
towards understanding more [22]. These resources are tremendously necessary to 
scientists studying SARS-CoV-2 infections and provide a map and common refer-
ence points to reach the data for describing precisely viral transcripts and ORFs. 
Comparison of different genomic organizations among all the SARS-CoV-2 isolates 
forms a starting point to determine the evolutionary relationships in this virus 
family. The most important point that should not be missed is the instability of 
the nucleotide sequences in the virus genome, which causes high ratio mutations. 
Viral genomes data inherently in GenBank involves missing annotated parts that 
sequence needs to be corrected. Annotations of viral genomes conducted with the 
best tools are available to test gene prediction with precise algorithms to identify 
new genes [23]. The annotation process may cause inconsistent findings for differ-
ent genomes as the terminology used to describe gene function [24]. Viral genomes 
need to be updated and re-annotated as additional strains are of importance for 
comparing sequences for the continual annotation process considering analogous 
by released versions in NCBI [25].
The RNA sequence and structure of the genomes could be easily sequenced, but 
to predict their role in infection with any certainty seems difficult at the course of 
an infection. In vitro experimentation results should prove the different ORFs iden-
tified through algorithms such as codon/pair usage, dinucleotide/junction usage, 
RNA structure differentiation which are detected by bioinformatics tools on a viral 
infection [26]. Even microarray using oligonucleotide probes to hybridize with 
putative exons and splice junctions could be beneficial for following the expression 
of predicted transcripts and splice variants in virus genome [27], single-cell RNA 
sequencing analysis of SARS-CoV-2 will help define how the virus integrates into a 
human as use host cell organization to regulate and code for all the required biologic 
process [28]. As this knowledge with different biological assays increasingly sup-
ports findings on SARS-CoV-2 and its pathogenic behavior, the proteomics data 
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obtained on up/down-regulated expression levels expressed by the virus reflects 
ongoing RNA transcripts that can be evaluated as biological cases related to post-
translational processing playing role in protein formation complexity. Proteomics 
methods have also the potential to follow the modification of viral gene products 
during viral infection, which will help to characterize how post-translation modi-
fication that affects viral replication. Since omics technology maybe not sufficient 
alone to find effective compounds inhibiting viral replication and invasive nega-
tive effects that occurred on the human body, we should consider the detection 
of the genomic parts showing stability without a high mutation ratio to design 
targeted molecules with inhibitory potential [13]. Genomic screening using specific 
algorithms to identify conserved motifs and to predict protein structure could be 
an efficient way to understand protein functions [29]. In immunological studies, 
model organism, yeast, thanks to its two-hybrid (Bait and Prey) system that can be 
suggested to prove the protein–protein interactions among viral-cellular proteins 
and potential gene products cooperating in biological processes can be clarified by 
the construction of protein–protein interaction maps [30].
4. Drug discovery by means of omics data on SARS-CoV-2
Genomics and proteomics are promising new areas affecting apparently  
whole biological fields with widespread data and tools provided by databases. 
Figure 1. 
The experiment-based approach is activity-based repositioning of original drugs for new pharmacological 
indications based on experimental assays, which involves protein target-based and cell/organism-based 
screening in vitro and/or in vivo assays. These studies are followed with cell assay, animal model approach and 
clinical approach. Illustration was created with BioRender.com by the authors of this chapter.
5
Utilization from Computational Methods and Omics Data for Antiviral Drug Discovery…
DOI: http://dx.doi.org/10.5772/intechopen.98319
The DNA Data Bank of Japan (DDBJ)(https://www.ddbj.nig.ac.jp/), GISAID 
initiative (https://www.gisaid.org/), National Center for Biotechnology 
Information (The GenBank)(http://www.ncbi.nlm.nih.gov/) and The European 
Bioinformatics Institute (EMBL-EBI) (http://www.ebi.ac.uk/) are important 
resources to researchers as nucleotide databases provided on the web. Most 
functions in micro/ macro organism are directed by interactions of proteins 
and ligands. Hence, computational techniques comprising in silico techniques 
to predict the protein complex formed can be remarkably cheaper and quicker 
than experimental methods. They are being a guide for subsequent targeted 
experiments before initiating in vitro studies cause of their predictive capability. 
Predicting the binding possibilities of multiple proteins is critical for understand-
ing their biological function in any target organism to design of drugs addressing 
the impairment of biological processes (Figure 1). Many solutions generated from 
a pair of static molecular structures with scoring function comprise the specific 
position of each atom, giving rise to the simulation of modeling that is seriously 
sensitive to the specific packing of atoms at the interface [31–33]. For modeling 
the protein, dynamics and correct protein arrangement are required, considering 
scoring functions related to the feature of docking poses using techniques such as 
molecular dynamics (MD) [34, 35].
5. Importance of drug discovery and molecular docking
The docking method relies on steric complementarity at the protein–protein 
interface level. These interfaces are observed in co-crystallized complexes available 
in the Protein Data Bank (PDB). They have been the major driving force in the 
development of docking with the addition of physicochemical and statistics-based 
properties [36, 37].
Homology modeling and protein prediction analysis enables us to test different 
proteins on SARS-CoV-2 with various ligands. Analysis by protein-ligand docking 
servers (Table 1) is available for geometric shape complementarity score (GSC 
score) and approximate interface area (AI area). Additionally, different software-
based tools for molecular dynamic analysis could be used. The interaction analysis 
of protein-ligand complexes and their amino acid position with bond distances 
calculated and visualized through the software provides an opportunity for molecu-
lar docking simulations. Protein docking servers can confirm the results within the 
protein and ligand [44]. They can get an insight into their all binding preferences 
within the active site of the protein and ligand (Figure 2).
Program Country Year Reference
AADS India 2011 [38]
AutoDock Vin USA 2010 [39]
BetaDock South Korea 2011 [40]
LigDockCSA South Korea 2011 [41]
PythDock South Korea 2011 [42]
VoteDock Poland 2011 [43]
Table 1. 
List of most commonly used protein-ligand softwares, comprising the updated ones.
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6.  The effect of circadian rhythm on SARS-CoV-2-infection and host 
immune response
Many physiological processes influenced by 24-hour circadian rhythms has 
been known within individual cells. Even virology and circadian rhythms seem 
like different fields of biology, studies have suggested a novel interaction between 
viral infection and the circadian clock [45]. Edgar et al. showed 10 times higher 
viral replication in the mice infected at the start of their resting phase, likely as 
late evening for humans [45]. The finding confirmed the relationship between the 
circadian phase and virus infection. This data shows viral infection can directly 
affect the advantage of physiological rhythms in combating viruses. Noteworthy, 
a new study also indicated that the expression of the genes exhibited circadian 
rhythm in monocytes are shifting between two-time points showing the active and 
the resting periods in human individuals, which also indirectly affects SARS-CoV-2 
replication [46]. The drug intake should also be adjusted considering the circadian 
rhythm of the body and virus to increase the efficacious of inhibitory compounds 
(Figure 3).
Another study also shows circadian clock has a central role in coordinating daily 
physiological processes involving immunity and biological process that humans 
are more susceptible to infections at certain times of the day cause of the function 
related to defense systems (Figure 3) with a daily rhythmic pattern [47]. In viral 
diseases, deciphering the complex relationships between circadian timekeeping, 
host immunity, and host-virus interactions has a great potential to unravel the com-
plexity of severe acute respiratory syndrome coronavirus pathogenicity. Infection 
severity which may be regulated by the circadian clock affecting therapy positively 
against the novel pathogen may also result in recession of the pathogen. Therefore, 
circadian nature accounted for responses needs urgent studies on clock–infection 
biology in SARS-CoV-2. Even the pathophysiology of SARS-CoV-2 infection and 
its severe complications are not well understood, SARS-CoV-2 severity may also 
depend on day-night cycle (Figure 3). The battle between virus replication and 
its neutralization by the host immune system could move simultaneously with the 
circadian activity phase of the host. Accelerating the activity of circadian immunity 
factors may help to control virus replication, as circadian clocks provide a competi-
tive advantage to the host against SARS-CoV-2.
Figure 2. 
Protein- ligand interaction illustration from Baysal et al. [13]. Arrows indicate the binding possibilities.
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As known defect on the circadian clock in hosts causes increasing of pathogen 
replication and invasion, which indicates that the severity of infection influenced 
by circadian rhythms. All these cases can be followed by omics technologies com-
prising genomics, transcriptomics and proteomics data [48, 49]. We stress the 
combination of the whole omics data to understand all biological cases related to 
SARS-CoV-2 and host defense mechanism. In consequence, exact treatment times 
aiming to control of virus will provide higher success in managing the disease. 
Circadian Expression Profiles Database (CircaDB) (http://circadb.hogeneschlab.
org/) could be beneficial for the evaluation of omics data with expression profiles 
related to the circadian clock [50]. Notably, the expression profiles of potential drug 
targets considering the circadian rhythm of the host could provide a new strategy 
for effective compounds depending on application doses, which may affect the effi-
ciency of tested pre-purposed or novel compounds. We need to better understand 
how the circadian clock affects SARS-CoV-2 infection to optimal clinical manage-
ment of the virus.
Another highlighted point for drawing the attention of the scientists, virulent 
agents causing infections could help to shape our genome that is also responsible for 
various polymorphic structure involving many loci related to MHC antigen process-
ing [51]. There is also strong evidence on the effect of the virus infection depending 
on HLA allele’s expression [52], even their influence is moderate level. Accordingly, 
the resistance to pathogens comprising viruses conferred by several genes acts at 
different stages of the host-pathogen interaction. The finding on another virus 
HIV at least 250 genes affecting the success of the infection has been demonstrated 
[53]. Consequently, the lack of genes or its impairment could have a negative or less 
effect on the virus invasion. These cases arise from deficient genes which lead to 
increased susceptibility to different virus infections [54].
Figure 3. 
Cellular clock affects the virus life cycle (1) which directly/ indirectly influenced by circadian clock of the host 
cell. These cases trigger multiple steps in regulation of different pathways (2) against virus and its replication 
phases involving particle genesis. In addition, immune responses combating viral infections regulated by 
circadian clocks could change depending on day and night (3). Illustration was created with BioRender.com by 
the authors of this chapter.
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7. Mutational changes in virus genome and traceability
As the inherent property of the virus genome, there is a higher mutational 
tendency compared to other micro/macro-organisms. The RNA virus replication 
does not comprise proofreading, as in the DNA cycle that this case renders genetic 
material to convenient for missing in the transcriptional phase [55]. This feature of 
RNA virus replication gives rise to high mutation possibility and formation of high 
yields, occurring of replication in a short time. RNA virus replication involves a 
complex and dynamic mutant formation ratio in certain genomic sites affecting the 
nucleotide sequence, caused by environmental factors. The model described for the 
evolution of virus shows comprehensible pathogenic behavior as quasispecies that 
have special population structure with a huge number of variant genomes relied on 
mutations [56]. These high mutation rates raised continually are changing in the 
relative frequency of the replication and selection. This process is the adoption of 
primitive replicons involving mutant distributions as seen in RNA viruses within 
their host [56, 57].
This mutational tendency depends on the population size of the virus involved 
in the infection. Therefore, a large population results in rapid fitness for cellular 
organisms. An important challenge in studies on RNA virus evolution is the dif-
ferentiation, depending on phenotypic traits with ongoing specific mutations. They 
may associate different mutations with the biological behavior of the virus, which 
may be existence for the expression of phenotypic traits. These cases are the reason 
for the formation of restricted types. The findings on epidemiological, functional 
genomics, and structural studies showed the tolerance of the genetic changes on 
RNA viruses which are indispensable characteristic properties stemming from the 
virus evolution. However, the extinction of the viral infection cannot be estimated 
just from the characteristics of the existing sequence that is an unpredictable 
transitional phase of the genetic information based on lethal mutagenesis. Relied 
on the genomic data, the mutational ratio on viral sequences can be easily followed, 
but the effect of the mutation resulted in less epidemical and pathogenic behavior 
cannot be determined without clinical studies and monitoring on the host. Even 
the omics science provides predicational data on the virus, this is not enough alone 
if not supported by filiation studies on epidemic cases. This mutation limiting the 
pathogenicity of the virus may result in alternative solutions occurring spontane-
ously in nature for ending the viral infections.
8. Future outlook
According to our current knowledge on SARS-CoV-2, our facilities limit to the 
efficient management of the disease and do not be enough to cut down the severity 
of the pathogen invasion except for protective methods relied on vaccination. Even 
it seems a major alternative method within other possibilities we are not sure how 
long the virus will keep its genetic stability without the mutation, which will not 
render all developed vaccines possible and effective approach for further infection 
waves. Particularly, we now need to determine whether SARS-CoV-2 is also more 
severe at certain times of the day or not, which is directly related with crosstalk 
between the circadian clocks and viral infections besides immunological strategies 
based on vaccination. Drug designing or testing of pre-purposed compounds with 
high potential inhibitory on viral replication should be accelerated without wast-
ing time. We are not sure what will tomorrow bring us and how other biotic and 
abiotic reasons will affect the pathogenicity and genetically that may change the 
SARS-CoV-2 and other viruses.
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9. Conclusions
Given the existing advanced techniques present today for following the genetic 
structure of the RNA viruses, we are able to find a solution for combating them. But 
it is possible to face the novel viruses that appeared in further periods in the world 
cause of shifting in ecological balance and the negative effect of global warming. 
We should be prepared for the further worst epidemic scenarios resulted from 
not only due to the virus but also by other microorganisms. It appears this kind of 
devastating case will be not the last one if the human being continues wasting of the 
irreversible property of nature and ecological biodiversity. As the genetic material 
RNA, viruses have their own unique repair process that emerged as early as 3.5 to 
2.5 billion years ago in the crust of the world. The uncovered genomic data puts 
insights on many biological processes for deciphering the dramatic scientific cases 
threatening world health, environmental issues. We believe that the post-genomic 
area at which we have completed genomic characterization of whole macro/ 
micro-organisms will serve for the harvesting of the fruits, which will be useful 
for the scientists. The data on the genome sequences available, already /or will be 
soon, will offer all the information concerning the threats such as SARS-CoV-2. 
Bioinformatics will have a dramatic impact on improving our understanding of this 
kind of unclear cases. Omics science and yielded purified data are expected to be an 
important contributor to the global issues waiting for outbreaks cause of pandemic 
cases. Researches in this field will play a major role and will impact drug discovery 
and pharmaceutical development comprising health care and the environment.
We stress in this chapter; bioinformatics tools will increase the potential of cur-
ing the diseases and producing new effective solutions besides accurately correlated 
clinical parameters of patient responsiveness to therapy. Bioinformatics used in 
the building of global databases in molecular microbiology to enhance the accu-
mulative knowledge in the purpose of the experimental data and meta-data about 
microorganisms. Drastically, whole bioinformatics tools and data yielding with 
omics science involving data mining will establish dynamically updated and flexible 
portals upon the novel microbial diversity with biotechnological innovations by our 
efforts aimed to reach end-products.
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